MedPath

Succinylcholine Chloride

Succinylcholine Chloride Injection, USP

Approved
Approval ID

4a63029a-a7c6-43f7-b485-c14ef7a4e92b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 30, 2023

Manufacturers
FDA

Nexus Pharmaceuticals Inc

DUNS: 620714787

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Succinylcholine Chloride

PRODUCT DETAILS

NDC Product Code14789-104
Application NumberANDA213552
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 30, 2023
Generic NameSuccinylcholine Chloride

INGREDIENTS (6)

Succinylcholine ChlorideActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB
MethylparabenInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PropylparabenInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Succinylcholine Chloride - FDA Drug Approval Details